Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (771-780 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|January 4, 2012
Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancerJennifer A Locke, Gaetano Zafarana, Chad A Malloff, et al.
The Prostate|January 4, 2012
LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signalingDongxia Ge, Allen C Gao, Qiuyang Zhang, et al.
The Prostate|November 19, 2011
RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapyHirotoshi Kawata, Naoki Shimada, Tomoko Kamiakito, et al.
The Prostate|December 1, 2011
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancerTong Sun, Ming Yang, Shaoyong Chen, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
The Prostate|December 1, 2011
Prospects in radionuclide imaging of prostate cancerSusanne Lütje, Otto C Boerman, Catharina M van Rij, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1Bhavani Krishnan, Frank M Torti, Patricia E Gallagher, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesisBhavani Krishnan, Thomas L Smith, Purnima Dubey, et al.
The Prostate|June 7, 2012
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agentJessie R Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, et al.
The Prostate|August 13, 2013
PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressivenessMichael J Ahrens, Paul A Bertin, Edward F Vonesh, et al.
Pageof 609

Showing results (771-780 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|January 4, 2012
Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancerJennifer A Locke, Gaetano Zafarana, Chad A Malloff, et al.
The Prostate|January 4, 2012
LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signalingDongxia Ge, Allen C Gao, Qiuyang Zhang, et al.
The Prostate|November 19, 2011
RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapyHirotoshi Kawata, Naoki Shimada, Tomoko Kamiakito, et al.
The Prostate|December 1, 2011
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancerTong Sun, Ming Yang, Shaoyong Chen, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
The Prostate|December 1, 2011
Prospects in radionuclide imaging of prostate cancerSusanne Lütje, Otto C Boerman, Catharina M van Rij, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1Bhavani Krishnan, Frank M Torti, Patricia E Gallagher, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesisBhavani Krishnan, Thomas L Smith, Purnima Dubey, et al.
The Prostate|June 7, 2012
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agentJessie R Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, et al.
The Prostate|August 13, 2013
PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressivenessMichael J Ahrens, Paul A Bertin, Edward F Vonesh, et al.
Pageof 609